Balchem vs Innospec
BCPC and IOSP side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BCPC and IOSP compare
Balchem is the larger company, worth 2.8 times as much as Innospec ($5.5B against $2.0B).
Balchem grew revenue faster over the last twelve months (9.4% versus 4.7% for Innospec).
Both pay dividends: Balchem yields 0.55% and Innospec 2.2%.
Balchem scores higher on the StockData Score (19 against 14 for Innospec), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BCPC | IOSP |
|---|---|---|
| Size and price | ||
| Market cap | $5.5B | $2.0B |
| Share price | $173.14 | $80.39 |
| Change, 1 year | 10.1% | 7.4% |
| Change, 5 years | 3.4% | −7.9% |
| Beta (5Y) | 0.74 | 0.86 |
| Employees | 1,352 | 2,450 |
| StockData Score | ||
| Total score | 19 (better) | 14 |
| Valuation score | 2 | 4 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 5 (better) | 1 |
| Health score | 6 | 6 |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/E | 32.6× | – |
| P/S | 5.0× | 1.1× (better) |
| P/B | 4.1× | 1.4× (better) |
| EV/EBITDA | 19.5× | 8.5× (better) |
| PEG | 2.42 | – |
| Fair value | $151.06 | $109.30 |
| Margin of safety | −14.6% | 26.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 9.4% (better) | 4.7% |
| Revenue growth, 5Y average | 8.1% | 8.3% (better) |
| Net income growth (TTM) | 14.5% | – |
| EPS growth (TTM) | 16.2% | – |
| EPS growth, 5Y average | 12.8% | 32.1% (better) |
| Profitability | ||
| Gross margin | 36.5% (better) | 27.7% |
| Operating margin | 20.7% (better) | 8.8% |
| Net margin | 15.4% | – |
| Return on equity | 13.0% | – |
| Return on invested capital | 14.3% (better) | 12.4% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.47 | 2.95 (better) |
| Altman Z-score | 11.06 (better) | 5.12 |
| Piotroski F-score | 9 | – |
| Dividends and buybacks | ||
| Dividend yield | 0.55% | 2.2% (better) |
| Payout ratio | 18.0% | – |
| Years of dividend growth | 3 | 12 (better) |
| Dividend growth, 5Y average | – | 10.5% |
| Buyback yield | 2.3% (better) | 0.68% |
| Shareholder yield | 2.8% | 2.9% (better) |
| Ownership | ||
| Held by institutions | 91.3% | 101% |
| Held by insiders | 0.72% | 1.6% |
| Insider net buying, 12 months | −$2.2M | −$874K (better) |
| Short interest, % of float | 1.6% | 1.9% |
Go deeper
- BCPC stock overview
- BCPC income statement
- BCPC valuation and score
- IOSP stock overview
- IOSP income statement
- IOSP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.